| 2019-12 |
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia |
Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150. |
 |
| 2019-11-27 |
Characterization of a fiber bundle-based real-time ultrasound/photoacoustic imaging system and its in vivo functional imaging applications |
Micromachines. 2019 Nov 27;10(12):Article number 820. |
|
| 2019-10 |
The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan |
Cancer Epidemiology, Biomarkers and Prevention. 2019 Oct;28(10):1694-1703. |
|
| 2019-10 |
A randomized controlled, open label, adaptive phase III Trial to evaluate safety and efficacy of endoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FO |
Annals of Oncology. 2019 Oct;30(Suppl. 5):321. |
|
| 2019-09 |
Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors |
Oncogene. 2019 Aug;38:6550-6565. |
|
| 2019-09 |
Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8 |
Theranostics. 2019 Sep. 23;9(24):7168-7183. |
|
| 2019-07-28 |
Nomogram for predicting survival in patients treated with liposomal irinotecan plus fluorouracil and leucovorin in metastatic pancreatic cancer |
Cancers. 2019 Jul 28;11(8):Article number 1068. |
|
| 2019-07 |
Preventive hypothermia as a neuroprotective strategy for paclitaxel-induced peripheral neuropathy |
Pain. 2019 Jul;160(7):1505-1521. |
|
| 2019-07 |
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer |
Journal of Hematology and Oncology. 2019 Jul;12:Article number 79. |
|
| 2019-06-24 |
Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication |
Journal of Clinical Medicine. 2019 Jun 24;8(6):Article number 903. |
|
| 2019-06-21 |
Identification of phenothiazine as an ETV1targeting agent in gastrointestinal stromal tumors using the Connectivity Map |
International Journal of Oncology. 2019 Jun 21;55(2):536-546. |
|
| 2019-06 |
Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol |
BMC Cancer. 2019 Jun;19:Article number 640. |
|
| 2019-05-27 |
Deciphering the potential role of hox genes in pancreatic cancer |
Cancers. 2019 May 27;11(5):Article number 734. |
|
| 2019-05-20 |
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer |
Molecular Cancer. 2019 May 20;18:Article number 96. |
|
| 2019-05 |
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial |
Journal of Geriatric Oncology. 2019 May;10(3):427-435. |
|
| 2019-04-17 |
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma |
Cancers. 2019 Apr 17;11(4):Article number 547. |
|
| 2019-04-10 |
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants |
Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957. |
|
| 2019-04-08 |
Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes |
BMC Cancer. 2019 Apr 8;19:Article number 337. |
|
| 2019-03 |
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens |
Gastric Cancer. 2019 Mar;22(2):344-354. |
|
| 2019-03 |
Foreword |
Hepatobiliary Surgery and Nutrition. 2019 Mar;8(Suppl. 1):S1. |
|
| 2019-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling |
Oncogene. 2019 Feb;38(8):1340-1353. |
|
| 2019-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.] |
Oncogene. 2019 Feb;38(8):1354. |
|
| 2019-02 |
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (attraction-4) |
Annals of Oncology. 2019 Feb;30(2):250-258. |
|
| 2019-02 |
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors |
European Journal of Cancer. 2019 Feb;108:78-87. |
|
| 2019-01 |
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin |
European Journal of Cancer. 2019 Jan;106:24-33. |
|
| 2019-01 |
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS |
Annals of Oncology. 2019 Jan;30(1):19-33. |
|
| 2019-01 |
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS |
Annals of Oncology. 2019 Jan;30(1):34-43. |
|
| 2019-01 |
Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer |
Theranostics. 2019 Jan;9(2):324-336. |
|
| 2018-12-20 |
Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression |
Cancers. 2018 Dec 20;11(1):Article number 8. |
|
| 2018-11-13 |
From friend to enemy: Dissecting the functional alteration of immunoregulatory components during pancreatic tumorigenesis |
International Journal of Molecular Sciences. 2018 Nov 13;19(11):Article number 3584. |
|
| 2018-11-07 |
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial |
European Journal of Cancer. 2018 Nov 7;105:71-78. |
|
| 2018-11 |
The incidence and survival of pancreatic cancer by histology, including rare subtypes: A nation-wide cancer registry-based study from Taiwan |
Cancer Medicine. 2018 Nov;7(11):5775-5788. |
|
| 2018-08-24 |
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor |
Cancer Science. 2018 Nov;109(11):3591-3601. |
|
| 2018-07 |
The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients |
Journal of the Chinese Medical Association. 2018 Jul;81(7):593-598. |
|
| 2018-06 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma |
Annals of Oncology. 2018 Jun;29(6):1402-1408. |
|
| 2018-04 |
The role of consolidation chemoradiotherapy in Locally Advanced Pancreatic Cancer receiving chemotherapy: An updated systematic review and meta-analysis |
Cancer Research and Treatment. 2018 Apr;50(2):562-574. |
|
| 2018-04 |
Dialysis increases the risk of bladder recurrence in patients with Upper Tract Urothelial Cancer: A population-based study |
Annals of Surgical Oncology. 2018 Apr;25(4):1086-1093. |
|
| 2018-03 |
Beau's lines in nails: An indicator of recent Docetaxel and 5-FU use |
Kaohsiung Journal of Medical Sciences. 2018 Mar;34(3):181-183. |
|
| 2018-03 |
Cure of unresectable, locally advanced pancreatic cancer after multidisciplinary therapy |
Journal of Cancer Research and Practice. 2018 Mar;5(1):27-31. |
|
| 2018-02-01 |
Myeloid-derived macrophages and secreted HSP90alpha induce pancreatic ductal adenocarcinoma development |
OncoImmunology. 2018 Feb 1;7(5):Article number e1424612. |
|
| 2018-01 |
Orchestration of H3K27 methylation: Mechanisms and therapeutic implication |
Cellular and Molecular Life Sciences. 2018 Jan;75(2):209-223. |
|
| 2018-01 |
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer; A JSMO - ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS |
Annals of Oncology. 2018 Jan;29(1):44-70. |
|
| 2018-01 |
Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma |
Journal of Clinical Oncology. 2018 Jan;36(3):276-282. |
|
| 2017-12 |
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial |
Lancet. 2017 Dec;390(10111):2461-2471. |
|
| 2017-10-24 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan |
Journal of the Formosan Medical Association. 2018 May;117(5):381-403. |
|
| 2017-10-09 |
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors |
Oncotarget. 2017 Oct 09;8(61):103613-103625. |
|
| 2017-10 |
Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review |
Cancer Research and Treatment. 2017 Oct;49(4):851-868. |
|
| 2017-10 |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma |
Scientific Reports. 2017 Oct;7:Article number 14333. |
|
| 2017-09-16 |
The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors |
Oncotarget. 2017 Sep 16;8(58):98068-98083. |
|
| 2017-09 |
KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model |
Oncogene. 2017 Sep;36(39):5532-5543. |
|
